iMetabolic Biopharma Corporation Revenue

Biotechnology Research • Tempe, Arizona, United States • 1-10 Employees

iMetabolic Biopharma Corporation revenue & valuation

Annual revenue	$684,440
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,200,000
Total funding	No funding

Key Contact at iMetabolic Biopharma Corporation

Urban A. Kiernan

Founder, Board Chairman And Ceo

Company overview

Headquarters	2155 E. Conference Dr., 104, Tempe, AZ 85284, US
Phone number	+14809395770
Website	imbiopharma.com
NAICS	541714
SIC	283
Keywords	Hyperlipidemia, Obesity, Metabolism, Cholesterol, Heart Disease, Drug Discovery And Development, Alzheimer'S Disease, Biopharma, Techbio, Cardio Metabolic Disease, Cardio Vascular Disease
Founded	2017
Employees	1-10
Socials

iMetabolic Biopharma Corporation Email Formats

iMetabolic Biopharma Corporation uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@imbiopharma.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@imbiopharma.com	100%

About iMetabolic Biopharma Corporation

iMetabolic Biopharma Corporation (iMBP) is an exciting early stage platform biopharma company that is developing First In Class therapeutics for the treatment of a number of diseases with high unmet medical need. Through the application of its proprietary iPlatform technology, iMBP has established itself as a Leader in TechBio, a nouveau field of drug discovery and development driven by technology innovation. Having already established a pipeline of five early stage therapeutic assets, with additional molecules already in design phase, iMBP is at the precipice in its next leg of evolution. Based in Tempe, AZ; iMBP is growing its operations to support the development of both its platform technology and therapeutic pipeline. iMBP is now strategically poised to become a disruptive force in the biopharma industry and is poised to move forward ground breaking science to help improve patient care. https://l.instagram.com/?u=https%3A%2F%2Flinktr.ee%2Fdr_urban_a_kiernan&e=AT1Hx7OAnm1Esgp1qPUsti_FJonAgqb7-BwI4lYRA9yTEVPRIqaN-v1miB74Ka5wcsiVCE1FOqkFLE20WA0uLkhLAuE9FDNspJfc3w

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry

C-Suite

Employees by Department

iMetabolic Biopharma Corporation has 3 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore iMetabolic Biopharma Corporation's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-09-03	9	N/A

Funding Insights

Number of funding rounds

iMetabolic Biopharma Corporation Tech Stack

Discover the technologies and tools that power iMetabolic Biopharma Corporation's digital infrastructure, from frameworks to analytics platforms.

Constant Contact

GoDaddy

Hosting

GoDaddy Website Builder

CMS

Open Graph

Miscellaneous

HSTS

Security

RequireJS

JavaScript frameworks

React

JavaScript frameworks

PWA

Miscellaneous

Frequently asked questions

iMetabolic Biopharma Corporation is located in Tempe, Arizona, US.

You can reach iMetabolic Biopharma Corporation at +14809395770.

iMetabolic Biopharma Corporation generates an estimated annual revenue of $684,440. This revenue figure reflects the company's market position and business performance in its industry.

iMetabolic Biopharma Corporation has an estimated valuation of $2,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

iMetabolic Biopharma Corporation was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

iMetabolic Biopharma Corporation has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at iMetabolic Biopharma Corporation

Urban A. Kiernan

Founder, Board Chairman And Ceo

4.8

40,000 users